Statin use has negative clinical impact on non-germinal center in patients with diffuse large B cell lymphoma in rituximab era. Issue 2 (February 2015) - Song, Moo-Kon
Highlights Inhibitory effect of rituximab by statin may be based on ratio of cell-of-origin. In our study, non-GC type was found to be more affected by statin use. This result reflects that non-GC type might be a beneficiary of R-CHOP therapy.